GENEVA: For first time public health history end cancer in sight. World Health Organization WHO believes cervical cancer could become first cancer eliminated provided countries continue strengthen human papillomavirus HPV vaccination screening timely treatment.
More 600,000 women diagnosed cervical cancer every year approximately 280,000 lose lives disease. Kills woman every two minutes somewhere world about 9 in 10 deaths happen low middle-income countries. Yet one most preventable cancers.
According WHO 19 of 20 countries highest cervical cancer burden are its African Region. Sub-Saharan Africa highest incidence globally estimated over 117,000 new cases more 76,000 deaths annually representing nearly quarter global burden. Persistent infection carcinogenic HPV types underpins almost all cervical cancers.
*90-70-90:*
In 2020 WHO Member States adopted Global Strategy Accelerate Elimination Cervical Cancer Public Health Problem. Strategy established ambitious 90-70-90 targets outlining three critical interventions needed bring disease under control. Targets aim 90% girls fully vaccinated HPV by age 15, 70% women undergo high-performance screening by ages 35 45, 90% women identified cervical precancer invasive cancer receive appropriate treatment.
If targets achieved by 2030 countries could reach elimination threshold fewer than four cases per 100,000 women. Successful implementation could reduce more 40% new cases disease 5 million related deaths by 2050. Estimated US$3.20 returned economy every dollar invested through 2050 beyond owing increases women workforce participation. About 62 mn women lives could saved.
"Eliminating any cancer would have once seemed impossible dream, but we now have cost-effective evidence-based tools make dream reality," WHO Director-General Dr Tedros Adhanom Ghebreyesus.
*Progress:*
According WHO 166 countries introduced HPV vaccination national immunisation programmes while 96 countries adopted single-dose vaccination schedule. Global HPV vaccination coverage reached 33%. In 2022 only 7% women aged 30-49 ever screened HPV test.
Single-dose offers solid protection — WHO 2022 — school-based programs jump coverage Africa 28% 2022 to 40% 2023 making Africa region second highest coverage globally. Since 2019 number African countries implementing HPV vaccination nearly tripled regional coverage increased 18% 2020 about 47% by 2024 Rwanda exceeding 90% coverage set meet WHO elimination targets ahead 2030.
Australia Sweden approaching historic milestone eliminating cervical cancer public health problem while Rwanda demonstrating similar progress possible Africa several districts already meeting key WHO elimination targets.
Kenya advancing national elimination action plan transitioning single-dose vaccination expanding integrated screening services. Nurse Martha Wanjiru travels mobile clinic highlands Kiambu County bringing screening directly women urban settlements rural communities educating health.
Karen Teal Sisters network now over 100,000 strong organizing HPV vaccination drives screening campaigns push toward WHO targets.
*Screening changed:*
More countries adopting HPV testing more effective identifying women need preventive treatment than traditional Pap test visual inspection performed vinegar low-resource settings. WHO guidelines LMICs recommend pivot VIA cytology toward primary HPV DNA testing preferred screening method greater sensitivity detecting precancer longer reassurance negative result. Advise high-performance HPV test women aged 30-49 ages 25-49 women living HIV self-collected samples acceptable feasible increase access.
AI-assisted triage tools promise screening — timely validation further regulation WHO relevant regulatory bodies needed support integration national screening programs.
*Why it works:*
HPV vaccine protects HPV types cause most cervical cancers genital warts some other cancers. Works best before exposure HPV why given girls boys aged 9-14. Vaccinated women still need screening vaccine does not cover every high-risk HPV type.
Disease typically takes 15-20 years develop opportunity early detection timely intervention. Precancer treatment quick early cervical cancer curable. "Screen and treat" one visit prevented cancer developing.
Women living HIV six times more likely develop cervical cancer HPV types 16 18 account about 76% cases. Nigeria incidence 29 per 100,000 significantly above elimination threshold four fewer. More 15 mn girls vaccinated since 2023 only about 5% Nigerian women aged 30-49 ever screened compared global target 70%.
Dr Bajpai WHO 90-70-90 targets underline importance combining vaccination organised screening early diagnosis timely treatment. “Technology alone cannot eliminate cervical cancer. HPV vaccination, organised screening, timely diagnosis access treatment must work together.”
*Call:*
WHO urged governments sustain investment. Tedros World Cervical Cancer Elimination Day Nov 17: “We call all countries ensure every girl can get HPV vaccine; every woman knows when due screened; every woman diagnosed receives care needs without delay.”
Parents vaccinate girls 9-14. Vaccine safe free routine immunisation no evidence causes infertility. Women 30 above get HPV test every 5-10 years even vaccinated women living HIV begin screening age 25 repeat every 3-5 years.
Eliminate means not zero cases — fewer 4 per 100,000. First cancer ever.
#CervicalCancer #HPV #WHO #Vaccination #Screening #WomensHealth #Cancer #Elimination #Tedros #Health